Clinical Trial Update: Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of EP547 in healthy subjects and patients with cholestatic or uremic pruritus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis
• Kidney Failure
• Pruritus

Drugs mentioned

• EP547

Snippet

Sponsor: Escient Pharmaceuticals, Inc | Conditions: Pruritus, Cholestasis | Phase 1 | Status: COMPLETED | Results posted: 2023-06-12